These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1369359)
41. Foot-and-mouth disease virus subtyping by sequencing VP1 genes. Marquardt O; Adam KH Vet Microbiol; 1990 Jun; 23(1-4):175-83. PubMed ID: 2169671 [TBL] [Abstract][Full Text] [Related]
42. High yield expression in a recombinant E. coli of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development. Lee MS; Hseu YC; Lai GH; Chang WT; Chen HJ; Huang CH; Lee MS; Wang MY; Kao JY; You BJ; Lin W; Lien YY; Lin MK Microb Cell Fact; 2011 Jul; 10():56. PubMed ID: 21781331 [TBL] [Abstract][Full Text] [Related]
43. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein. Jun HS; Yoon SW; Kang Y; Pak CY; Lee MC; Yoon JW J Gen Virol; 1995 Oct; 76 ( Pt 10)():2557-66. PubMed ID: 7595359 [TBL] [Abstract][Full Text] [Related]
44. VP1-coding sequences of recent isolates of foot-and-mouth disease virus types A, O and Asia1. Marquardt O; Haas B Virus Genes; 1998; 16(2):185-93. PubMed ID: 9608664 [TBL] [Abstract][Full Text] [Related]
45. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. Abrams CC; King AM; Belsham GJ J Gen Virol; 1995 Dec; 76 ( Pt 12)():3089-98. PubMed ID: 8847514 [TBL] [Abstract][Full Text] [Related]
46. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum. Krebs O; Ahl R; Straub OC; Marquardt O Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514 [TBL] [Abstract][Full Text] [Related]
47. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477 [TBL] [Abstract][Full Text] [Related]
48. OmpA-FMDV VP1 fusion proteins: production, cell surface exposure and immune responses to the major antigenic domain of foot-and-mouth disease virus. Ruppert A; Arnold N; Hobom G Vaccine; 1994 May; 12(6):492-8. PubMed ID: 8036821 [TBL] [Abstract][Full Text] [Related]
49. Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Sobrino F; Palma EL; Beck E; Dávila M; de la Torre JC; Negro P; Villanueva N; Ortín J; Domingo E Gene; 1986; 50(1-3):149-59. PubMed ID: 3034729 [TBL] [Abstract][Full Text] [Related]
50. High-level expression of the simian virus 40 genes LP1, VP1 and VP2 as fusion proteins in Escherichia coli. Lowman HB; Behm M; Brown S; Bina M Gene; 1988 Aug; 68(1):23-33. PubMed ID: 2851492 [TBL] [Abstract][Full Text] [Related]
51. Comparative studies on immunoreactivity of truncated recombinant proteins of foot and mouth disease virus (FMDV) produced in E.coli and insect cells. Viswanathan S; Ratish G; Reddy GR; Suryanarayana VV Indian J Exp Biol; 1999 Jun; 37(6):536-40. PubMed ID: 10641184 [TBL] [Abstract][Full Text] [Related]
52. [Synthetic immunogenic complexes containing a peptide from the surface protein of the foot-and-mouth disease virus]. Rar VA; Makarov EA; Iurovskiĭ VV; Meshcheriakova EA; Andronova TM; Ivanov VT Bioorg Khim; 1990 Jul; 16(7):904-15. PubMed ID: 2173604 [TBL] [Abstract][Full Text] [Related]
53. Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Weddell GN; Yansura DG; Dowbenko DJ; Hoatlin ME; Grubman MJ; Moore DM; Kleid DG Proc Natl Acad Sci U S A; 1985 May; 82(9):2618-22. PubMed ID: 2986125 [TBL] [Abstract][Full Text] [Related]
54. Expression of the Foot-and-Mouth Disease Virus VP1 protein using a replication-competent recombinant canine adenovirus type 2 elicits a humoral antibody response in a porcine model. Liu Y; Hu R; Zhang S; Zhang F; Li Z; Wei X; Chen L Viral Immunol; 2006; 19(2):202-9. PubMed ID: 16817763 [TBL] [Abstract][Full Text] [Related]
55. Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona. Gomes P; Giralt E; Andreu D Vaccine; 2001 May; 19(25-26):3459-66. PubMed ID: 11348711 [TBL] [Abstract][Full Text] [Related]
56. Cloning and expression of coxsakievirus B3 viral protein-1 in E. coli. Maghsoudi N; Khalilpour A; Kamali M; Zeinoddini M Iran Biomed J; 2007 Jul; 11(3):147-52. PubMed ID: 18051774 [TBL] [Abstract][Full Text] [Related]
57. Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP. Bachrach HL; Morgan DO; McKercher PD; Moore DM; Robertson BH Vet Microbiol; 1982 May; 7(2):85-96. PubMed ID: 6287701 [TBL] [Abstract][Full Text] [Related]
58. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Mateu MG; Martínez MA; Rocha E; Andreu D; Parejo J; Giralt E; Sobrino F; Domingo E Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5883-7. PubMed ID: 2474821 [TBL] [Abstract][Full Text] [Related]
59. Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iran. Marquardt O; Freiberg B Vet Microbiol; 2000 Jun; 74(4):377-86. PubMed ID: 10831859 [TBL] [Abstract][Full Text] [Related]
60. [Recombinant plasmids containing hybrid protein genes with antigenic determinants of the foot and mouth virus]. Chernen'kaia EA; Gurevich AI; Korobko VG Bioorg Khim; 1989 Apr; 15(4):508-13. PubMed ID: 2473757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]